
SNDK · Nasdaq
| FY2027 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Total Revenue | $20.25B | $7.36B | $6.66B | $6.09B |
| Cost of Revenue | $5.78B | $5.14B | $5.59B | $5.66B |
| Gross Profit | $14.47B | $2.21B | $1.07B | $430.00M |
| Research & Development | $1.33B | $1.13B | $1.06B | $1.17B |
| Selling, General & Administrative | $676.00M | $573.00M | $455.00M | $558.00M |
| Operating Expenses | $2.08B | $3.59B | $1.54B | $2.46B |
| Operating Income | $12.39B | -$1.38B | -$468.00M | -$2.04B |
| Other Income / (Expense) | $628.00M | -$102.00M | -$35.00M | $33.00M |
| Income Before Taxes | $13.02B | -$1.48B | -$503.00M | -$2.00B |
| Provision for Income Taxes | $1.58B | $162.00M | $169.00M | $141.00M |
| Net Income | $11.43B | -$1.64B | -$672.00M | -$2.14B |
| Basic EPS | $77.78 | -$11.32 | -$4.63 | -$14.78 |
| Diluted EPS | $73.76 | -$11.32 | -$4.63 | -$14.78 |
| Basic Shares Outstanding | 147.00M | 145.00M | 145.00M | 145.00M |
| Diluted Shares Outstanding | 155.00M | 145.00M | 145.00M | 145.00M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Jun 2026 | $64.52 | $61.80 | $71.02 | 7 | ↑1 ↓0 |
| Jun 2027 | $208.92 | $192.48 | $230.24 | 7 | ↑0 ↓0 |
| Jun 2028 | $252.16 | $171.82 | $318.79 | 6 | ↑1 ↓0 |